Nvidia Fuels Discovery: $50M Investment Accelerates Recursion's AI Pharma Odyssey
About this episode
In this episode, we discuss the acceleration of AI-driven drug discovery in the pharmaceutical world as Nvidia fuels Recursion with a substantial $50 million investment. Join us as we explore the implications, the collaborative synergy, and the potential for groundbreaking advancements in medical science.
-
Invest in AI Box: https://Republic.com/ai-box
-
Get on the AI Box Waitlist: https://AIBox.ai/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Get every episode summarized
Each time Strict Scrutiny publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Strict Scrutiny
Google Stops AI Exploit, Nadella Testifies, OpenAI's New $4B Unit
Strict Scrutiny
Anthropic Aiming for $1 Trillion Valuation
Strict Scrutiny
Claude 'Dreaming': The Latest from Anthropic
Strict Scrutiny
Examining GPT 5.5's Features Critically
Strict Scrutiny